Evidence map›Paper›PMID 33257685›Full record

ArticleNature communications2020

muscat detects subpopulation-specific state transitions from multi-sample multi-condition single-cell transcriptomics data.

Helena L Crowell, Charlotte Soneson, Pierre-Luc Germain, Daniela Calini, Ludovic Collin, Catarina Raposo, Dheeraj Malhotra, Mark D Robinson

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 295 papers.

0numbers the graph read from it
0cells of the map it votes in
295citing papers in PubMed
22.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

295 citing papers in PubMed, 474 citations in OpenAlex.

  1. 4-1BBCell reports. Medicine · 2025
    Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. iScience · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. A pathogenic CD8⁺ TNature communications · 2026
    Article

235 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Helena L CrowellDepartment of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.ORCID 0000-0002-4801-1767
Charlotte SonesonDepartment of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
Pierre-Luc GermainDepartment of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
Daniela CaliniF. Hoffmann-La Roche Ltd., Pharma Research and Early Development, Neuroscience, Ophthalmology and Rare Diseases, Roche Innovation Center Basel, Basel, Switzerland.
Ludovic CollinF. Hoffmann-La Roche Ltd., Pharma Research and Early Development, Neuroscience, Ophthalmology and Rare Diseases, Roche Innovation Center Basel, Basel, Switzerland.
Catarina RaposoF. Hoffmann-La Roche Ltd., Pharma Research and Early Development, Neuroscience, Ophthalmology and Rare Diseases, Roche Innovation Center Basel, Basel, Switzerland.
Dheeraj MalhotraF. Hoffmann-La Roche Ltd., Pharma Research and Early Development, Neuroscience, Ophthalmology and Rare Diseases, Roche Innovation Center Basel, Basel, Switzerland.
Mark D RobinsonDepartment of Molecular Life Sciences, University of Zurich, Zurich, Switzerland. mark.robinson@imls.uzh.ch.ORCID 0000-0002-3048-5518
Roche (Switzerland) · CHSIB Swiss Institute of Bioinformatics · CHUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Single-cell RNA sequencing (scRNA-seq) has become an empowering technology to profile the transcriptomes of individual cells on a large scale. Early analyses of differential expression have aimed at identifying differences between subpopulations to identify subpopulation markers. More generally, such methods compare expression levels across sets of cells, thus leading to cross-condition analyses. Given the emergence of replicated multi-condition scRNA-seq datasets, an area of increasing focus is making sample-level inferences, termed here as differential state analysis; however, it is not clear which statistical framework best handles this situation. Here, we surveyed methods to perform cross-condition differential state analyses, including cell-level mixed models and methods based on aggregated pseudobulk data. To evaluate method performance, we developed a flexible simulation that mimics multi-sample scRNA-seq data. We analyzed scRNA-seq data from mouse cortex cells to uncover subpopulation-specific responses to lipopolysaccharide treatment, and provide robust tools for multi-condition analysis within the muscat R package.

Indexed as

TranscriptomeAnimalsCerebellar CortexCluster AnalysisComputational BiologyComputer SimulationGene Expression ProfilingLipopolysaccharidesMaleMiceModels, StatisticalRNA, Small CytoplasmicSequence Analysis, RNASignal TransductionSingle-Cell AnalysisSoftwareLipopolysaccharidesRNA, Small Cytoplasmic

Identifiers

PMID33257685
PMCPMC7705760
OpenAlexW3108941787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.